87 reactions · 34 shares | "It's like Netflix for medical lectures!"...

27K views · 280 reactions | Merck and partner Ridgeback Biotherapeutics said they specifically asked the U.S. Food and Drug Administration to grant emergency use authorization for their new drug, molnupiravir, to treat adults with mild-to-moderate COVID-19 who are at risk for severe disease or hospitalization. | CBC News | Facebook

2.8K views · 19 reactions | WebMD Chief Medical Officer Dr. John Whyte speaks with Dr. Peter Marks, Director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research, about the FDA's emergency use authorization revisions for convalescent plasma. | WebMD | Facebook